Suppr超能文献

长期口服盐酸西曲酸酯对Wistar大鼠实验性诱导肠化生的抑制作用。

Inhibitory effect of prolonged oral administration of cetraxate hydrochloride on experimentally-induced intestinal metaplasia in Wistar rats.

作者信息

Tatsuta M, Yamamura H, Iishi H, Taniguchi H

机构信息

Department of Gastrointestinal Oncology, Center for Adult Diseases, Osaka, Japan.

出版信息

Arzneimittelforschung. 1987 Sep;37(9):1045-8.

PMID:3435599
Abstract

The effect of cetraxate hydrochloride (Neuer) on the induction of intestinal metaplasia by intragastric instillation of 5% NaOH solution was investigated in Wistar rats. Oral administration of cetraxate, beginning 2 days after NaOH treatment, resulted in a significant increase in antral mucosal blood flow and a significant reduction in the incidence and amount of intestinal metaplasia in experimental week 25, but no significant changes in basal acid secretion or antral mucosal pH. On histological examination, goblet cell metaplasia were frequently seen. These results show that the increased gastric blood flow produced by cetraxate hydrochloride may be associated with the suppression of induction of intestinal metaplasias.

摘要

在Wistar大鼠中研究了盐酸西曲酸酯(Neuer)对通过胃内滴注5%氢氧化钠溶液诱导肠化生的影响。在氢氧化钠处理后2天开始口服西曲酸酯,在实验第25周时,胃窦黏膜血流量显著增加,肠化生的发生率和程度显著降低,但基础胃酸分泌或胃窦黏膜pH值无显著变化。组织学检查时,常见杯状细胞化生。这些结果表明,盐酸西曲酸酯产生的胃血流量增加可能与肠化生诱导的抑制有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验